Literature DB >> 16781708

Attenuation of experimental arthritis in TRPV1R knockout mice.

N J Barton1, D S McQueen, D Thomson, S D Gauldie, A W Wilson, D M Salter, I P Chessell.   

Abstract

The Transient Receptor Potential Vanilloid 1 (TRPV1R) is a ligand-gated, non-selective cation channel expressed predominantly by sensory neurons. TRPV1Rs respond to a variety of noxious stimuli including capsaicin, intense heat and acid. These factors, combined with behavioral studies, show that TRPV1Rs are involved in nociception. The aim of our study was to determine whether TRPV1Rs play a role in the development and maintenance of inflammation and mechanical hyperalgesia by studying the development of unilateral joint inflammation in TRPV1R-/- mice. Knee joints of TRPV1R-/- or wild-type (WT) mice were injected with FCA (200 microg) under temporary anesthesia, and the resulting inflammation and hyperalgesia measured for 35 days. Histological analysis was performed on joints at the end of the study. TRPV1R-/- mice developed mild joint swelling which was significantly less than that obtained in WT mice (P < 0.05, Mann-Whitney). The ratio of the weight distribution between the hind limbs in TRPV1R-/- mice was also significantly less than in WT mice (P < 0.05, Mann-Whitney). Neither swelling nor hypersensitivity was completely absent in the knockout mice, indicating either that other mechanisms are involved or that a compensatory mechanism operates in TRPV1R-/- mice. These results suggest that TRPV1 receptors are important for the development of joint inflammation and the associated mechanical hypersensitivity observed in this model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781708     DOI: 10.1016/j.yexmp.2006.04.007

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  30 in total

Review 1.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

Review 2.  Research progress in transient receptor potential vanilloid 1 of sensory nervous system.

Authors:  Da-Lu Liu; Wen-Ting Wang; Jun-Ling Xing; San-Jue Hu
Journal:  Neurosci Bull       Date:  2009-08       Impact factor: 5.203

3.  Peripheral group I metabotropic glutamate receptor activation leads to muscle mechanical hyperalgesia through TRPV1 phosphorylation in the rat.

Authors:  Man-Kyo Chung; Jongseok Lee; John Joseph; Jami Saloman; Jin Y Ro
Journal:  J Pain       Date:  2014-11-01       Impact factor: 5.820

Review 4.  ThermoTRPs and Pain.

Authors:  Robyn J Laing; Ajay Dhaka
Journal:  Neuroscientist       Date:  2015-01-21       Impact factor: 7.519

Review 5.  Sensory TRP channels: the key transducers of nociception and pain.

Authors:  Aaron D Mickle; Andrew J Shepherd; Durga P Mohapatra
Journal:  Prog Mol Biol Transl Sci       Date:  2015-02-12       Impact factor: 3.622

Review 6.  The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na(+) channel (ENaC): IUPHAR Review 19.

Authors:  Emilie Boscardin; Omar Alijevic; Edith Hummler; Simona Frateschi; Stephan Kellenberger
Journal:  Br J Pharmacol       Date:  2016-08-10       Impact factor: 8.739

7.  Increased expression of CGRP in sensory afferents of arthritic mice--effect of genetic deletion of the vanilloid receptor TRPV1.

Authors:  Yong Chen; Helen H Willcockson; Juli G Valtschanoff
Journal:  Neuropeptides       Date:  2008-09-11       Impact factor: 3.286

8.  Vanilloid receptor TRPV1-mediated phosphorylation of ERK in murine adjuvant arthritis.

Authors:  Y Chen; H H Willcockson; J G Valtschanoff
Journal:  Osteoarthritis Cartilage       Date:  2008-08-05       Impact factor: 6.576

9.  Vanilloid receptor TRPV1-positive sensory afferents in the mouse ankle and knee joints.

Authors:  Won Gil Cho; Juli G Valtschanoff
Journal:  Brain Res       Date:  2008-04-27       Impact factor: 3.252

10.  Trpv1 mediates spontaneous firing and heat sensitization of cutaneous primary afferents after plantar incision.

Authors:  Ratan K Banik; Timothy J Brennan
Journal:  Pain       Date:  2008-11-17       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.